Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Víctor Commendatore"'
Autor:
Víctor Commendatore
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 57, Iss 3Sup (2023)
En un editorial de la Revista de la Sociedad Argentina de Diabetes, en 1997, el Dr. Juan José Gagliardino nos decía que “los nuevos valores para el diagnóstico de la diabetes mellitus (DM) buscan una mejor correlación con la aparición de lesio
Externí odkaz:
https://doaj.org/article/73fa57a45fd5490c8d8e7f8b50d02236
Autor:
Víctor Commendatore
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 55, Iss 3Sup, Pp 19-24 (2021)
Islets of Langerhans' evolution, and within it, β cellular pool from normality to T2D undergoes several stages. Among them, it can be observed initial adaptative hyperplasia to insulin resistance and a later claudication with cellular mass reduction
Externí odkaz:
https://doaj.org/article/66c09a2a371d4c1b854e9ac670511d5a
Autor:
Dafne Walter, Gustavo Frechtel, Silvia Gorbán de Lapertosa, Víctor Commendatore, Alejandro Chertkoff, Adriana Villarino, Graciela Fuente
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 54, Iss 2, Pp 31-38 (2020)
Introduction: type 2 diabetes mellitus (T2DM) is a highly prevalent metabolic disease, which constitutes an important cardiovascular risk factor, in which patients are not only diagnosed late, but remain for prolonged times, with glycemic and other c
Externí odkaz:
https://doaj.org/article/e50111f6c7014ef6aec44bfb842047c7
Symposium 3: Impaired fasting glycemia: is it time to modify the cut-off value adopted by Argentina?
Autor:
Víctor Commendatore
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 56, Iss 3Sup, Pp 9-9 (2022)
At the end of the last century, in 1997, an International Committee of Experts convened by the American Diabetes Association (ADA) reassessed the classification and diagnostic criteria for diabetes mellitus (DM)1 defining, for the first time, the cat
Externí odkaz:
https://doaj.org/article/7bac7cf47a9f48708a63a96f1767caa0
Autor:
María Cristina Faingold, Víctor Commendatore, Claudio González, Julio César Bragagnolo, Isaac Sinay, Silvia Lapertosa, Fabiana Vázquez, Carla Musso, Jorge Alvariñas, Alejandro De Dios, Gustavo Daniel Frechtel, Susana Salzberg, Héctor Alejandro Serra, León Litwak, Juan José Gagliardino, Graciela Fuente, Cristian Suárez Cordo, Alicia Elbert, Carlos Buso, Susana Fuentes
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 50, Iss 2, Pp 64-90 (2016)
Objectives: 1) update the Guidelines for the Treatment of the Diabetes Mellitus Type 2 of the Argentine Society of Diabetes, published in 2010; 2) provide to the health team updated guidance for the therapeutic management of people with this disease.
Externí odkaz:
https://doaj.org/article/ef140e9d453f492aac5773d21d57eb45
Autor:
Víctor Commendatore
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 54, Iss 3Sup, Pp 77-77 (2020)
Symposium 19: Drug Treatment: What's New? Secretagogues: sulfonylureas and incretins Both SUs and iDPP4 have earned a spot within current Diabetes (DM) therapy. Regarding SUs, we refer to glimepiride, gliclazide and glipizide. Since glimepiride has
Externí odkaz:
https://doaj.org/article/60c6c98793dc4011bf7b39fc58facc04
Autor:
Víctor Commendatore, Cristina Faingold, Gustavo Frechtel, Graciela Fuente, Amelia Linari, Carla Musso, Miriam Tonietti
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 49, Iss 1, Pp 13-31 (2015)
Introduction: given the existence of significant limitations that may influence the injection technique and, therefore the evolution of the treatment of diabetes mellitus these recommendations were performed, which were adapted culturally to our coun
Externí odkaz:
https://doaj.org/article/775145ce96f041e988ecce8fbdbe6799
Autor:
Víctor Commendatore, M Zamboni, Pedro Godoy Bolzán, A Benmelej, F Tedesco, C González, P Frias
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 51, Iss 1, Pp 18-18 (2018)
Introduction: during daily practice we use different glucose sensors that allow us to make decisions, evaluate the results of treatment, prevent or treat risk situations and empower the patient with respect to their treatment, so it is essential to e
Externí odkaz:
https://doaj.org/article/7f4182ffa4534db8b7463fcb0de5a7b2
Autor:
Víctor Commendatore, Cristina Faingold, Cecilia Fenili, Gustavo Frechtel, Claudio González, Isabel Llanos, Carla Lucarelli, María del Carmen Maselli, Carmen Mazza, Félix Puchulu, Gabriela Ruibal, Silvina Valdez
Publikováno v:
Revista de la Sociedad Argentina de Diabetes. 57:9
Establecer el punto de corte entre la glucemia en ayunas normal y la alterada resulta de suma importancia a los efectos de considerar a un paciente en riesgo, tanto de progresar a estados más avanzados de la enfermedad como de sufrir complicaciones
Autor:
Matías Viniegra, Alfredo Martínez, Mauro Frusti, Pablo A Salgado, Luis Monaco, Juan José Gagliardino, Maria Gabriela Simesen de Bielke, Víctor Commendatore, Maria Zulema Chaila, Carlos Buso, Claudio Gonzalez
Publikováno v:
J Diabetes Sci Technol
Background: HbA1c result provide information on metabolic control in diabetes mellitus (DM) and could also be used for its diagnosis. For its determination, the laboratory must be certified by the National Glycohemoglobin Standardization Program (NGS